Brief: X4 Pharmaceuticals Q2 EPS USD 0.45 Vs. IBES Estimate USD 0.01
08/08/2024 11:01
Aug 08 (Reuters) - X4 Pharmaceuticals Q2 income from operations USD 71.103 million. * Q2 net income USD 90.833 million
Recent news on X4 Pharmaceuticals
See all newsBrief: X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
X4 Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: X4 Pharmaceuticals Q2 Operating Expenses USD 25.197 Million
X4 Pharmaceuticals Inc expected to post a loss of 18 cents a share - Earnings Preview
Brief: X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule